Synapse - Alexander Drilon

Search Within

Alexander Edward Drilon

Results (156)

Acquired resistance of EGFR-mutant lung cancer to AT790M-specificEGFR inhibitor: Emergence of a third mutation (C797S) in the EGFR tyrosine kinase domain

Journal Article

Yu, H. A.; Tian, S. K.; Drilon, A. E.; Borsu, L.; Riely, G. J.; Arcila, M. E.; Ladanyi, M.
JAMA Oncology (2015)

Fulltext@MSK | Save

Clinically adoption of MSK-IMPACT, a hybridization capture-based next generation sequencing assay, for the assessment of lung adenocarcinomas

Meeting Abstract

Arcila, M. E.; Zehir, A.; Yu, H.; Drilon, A.; Li, B. T.; Riely, G. J.; Rekhtman, N.; Lin, O.; Hyman, D.; Berger, M.; more...
Journal of Thoracic Oncology (2015)

Fulltext@MSK | Save

Response to MET inhibitors in stage IV lung adenocarcinoma patients with mutations that cause MET exon 14 skipping

Meeting Abstract

Paik, P.; Drilon, A.; Yu, H.; Rekhtman, N.; Borsu, L.; Ginsberg, M.; Berger, M.; Ladanyi, M.; Rudin, C. M.
Journal of Thoracic Oncology (2015)

Fulltext@MSK | Save

Patterns of RET and ROS1 FISH abnormalities seen in lung adenocarcinomas: A correlation study with targeted next-generation sequencing

Meeting Abstract

Wang, L.; Drilon, A.; Rao, M.; Aryeequaye, R.; Cao, L.; Islamdoust, N.; Shah, R.; Zehir, A.; Benayed, R.; Sadowska, J.; more...
Journal of Molecular Diagnostics (2015)

Fulltext@MSK | Save

Impact of concurrent PIK3CA mutations on response to EGFR tyrosine kinase inhibition in EGFR-mutant lung cancers and on prognosis in oncogene-driven lung adenocarcinomas

Journal Article

Eng, J.; Woo, K. M.; Sima, C. S.; Plodkowski, A.; Hellmann, M. D.; Chaft, J. E.; Kris, M. G.; Arcila, M. E.; Ladanyi, M.; Drilon, A.
Journal of Thoracic Oncology (2015)

Fulltext@MSK | Save

Broad, hybrid capture-based next-generation sequencing identifies actionable genomic alterations in lung adenocarcinomas otherwise negative for such alterations by other genomic testing approaches

Journal Article

Drilon, A.; Wang, L.; Arcila, M. E.; Balasubramanian, S.; Greenbowe, J. R.; Ross, J. S.; Stephens, P.; Lipson, D.; Miller, V. A.; Kris, M. G.; more...
Clinical Cancer Research (2015)

Fulltext@MSK | Save

Response to crizotinib and cabozantinib in stage IV lung adenocarcinoma patients with mutations that cause MET exon 14 skipping

Meeting Abstract

Paik, P. K.; Drilon, A. E.; Yu, H. A.; Krug, L. M.; Rekhtman, N.; Borsu, L.; Ginsberg, M. S.; Berger, M. F.; Ladanyi, M.; Rudin, C. M.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Phase II study of cabozantinib for patients with advanced RET-rearranged lung cancers

Meeting Abstract

Drilon, A. E.; Sima, C. S.; Somwar, R.; Smith, R.; Ginsberg, M. S.; Riely, G. J.; Rudin, C. M.; Ladanyi, M.; Kris, M. G.; Rizvi, N. A.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Comprehensive assessment of targetable alterations in lung adenocarcinoma samples with limited material using MSK-IMPACT, a clinical, hybrid capture-based, next-generation sequencing (NGS) assay

Meeting Abstract

Arcila, M. E.; Yu, H. A.; Drilon, A. E.; Riely, G. J.; Zehir, A.; Sadowska, J.; Hyman, D. M.; Kris, M. G.; Berger, M. F.; Ladanyi, M.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring met mutations causing exon 14 skipping

Journal Article

Paik, P. K.; Drilon, A.; Fan, P. D.; Yu, H.; Rekhtman, N.; Ginsberg, M. S.; Borsu, L.; Schultz, N.; Berger, M. F.; Rudin, C. M.; more...
Cancer Discovery (2015)

Fulltext@MSK | Save